Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells

Pratibha Singh, Jonathan Hoggatt, Malgorzata Kamocka, Khalid Mohammad, Mary R. Saunders, Hongge Li, Jennifer Speth, Nadia Carlesso, Theresa Guise, Louis Pelus

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Endothelial cells (ECs) are components of the hematopoietic microenvironment and regulate hematopoietic stem and progenitor cell (HSPC) homeostasis. Cytokine treatments that cause HSPC trafficking to peripheral blood are associated with an increase in dipeptidylpeptidase 4/CD26 (DPP4/CD26), an enzyme that truncates the neurotransmitter neuropeptide Y (NPY). Here, we show that enzymatically altered NPY signaling in ECs caused reduced VE-cadherin and CD31 expression along EC junctions, resulting in increased vascular permeability and HSPC egress. Moreover, selective NPY2 and NPY5 receptor antagonists restored vascular integrity and limited HSPC mobilization, demonstrating that the enzymatically controlled vascular gateway specifically opens by cleavage of NPY by CD26 signaling via NPY2 and NPY5 receptors. Mice lacking CD26 or NPY exhibited impaired HSPC trafficking that was restored by treatment with truncated NPY. Thus, our results point to ECs as gatekeepers of HSPC trafficking and identify a CD26-mediated NPY axis that has potential as a pharmacologic target to regulate hematopoietic trafficking in homeostatic and stress conditions.

Original languageEnglish (US)
Pages (from-to)4527-4540
Number of pages14
JournalJournal of Clinical Investigation
Volume127
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Neuropeptide Y
Hematopoietic Stem Cells
Blood Vessels
Endothelial Cells
Hematopoietic Stem Cell Mobilization
Intercellular Junctions
Capillary Permeability
Cellular Structures
Neurotransmitter Agents
Homeostasis
Cytokines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells. / Singh, Pratibha; Hoggatt, Jonathan; Kamocka, Malgorzata; Mohammad, Khalid; Saunders, Mary R.; Li, Hongge; Speth, Jennifer; Carlesso, Nadia; Guise, Theresa; Pelus, Louis.

In: Journal of Clinical Investigation, Vol. 127, No. 12, 01.12.2017, p. 4527-4540.

Research output: Contribution to journalArticle

Singh, Pratibha ; Hoggatt, Jonathan ; Kamocka, Malgorzata ; Mohammad, Khalid ; Saunders, Mary R. ; Li, Hongge ; Speth, Jennifer ; Carlesso, Nadia ; Guise, Theresa ; Pelus, Louis. / Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells. In: Journal of Clinical Investigation. 2017 ; Vol. 127, No. 12. pp. 4527-4540.
@article{3c5f53f5078045438a86f45a8d9a6441,
title = "Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells",
abstract = "Endothelial cells (ECs) are components of the hematopoietic microenvironment and regulate hematopoietic stem and progenitor cell (HSPC) homeostasis. Cytokine treatments that cause HSPC trafficking to peripheral blood are associated with an increase in dipeptidylpeptidase 4/CD26 (DPP4/CD26), an enzyme that truncates the neurotransmitter neuropeptide Y (NPY). Here, we show that enzymatically altered NPY signaling in ECs caused reduced VE-cadherin and CD31 expression along EC junctions, resulting in increased vascular permeability and HSPC egress. Moreover, selective NPY2 and NPY5 receptor antagonists restored vascular integrity and limited HSPC mobilization, demonstrating that the enzymatically controlled vascular gateway specifically opens by cleavage of NPY by CD26 signaling via NPY2 and NPY5 receptors. Mice lacking CD26 or NPY exhibited impaired HSPC trafficking that was restored by treatment with truncated NPY. Thus, our results point to ECs as gatekeepers of HSPC trafficking and identify a CD26-mediated NPY axis that has potential as a pharmacologic target to regulate hematopoietic trafficking in homeostatic and stress conditions.",
author = "Pratibha Singh and Jonathan Hoggatt and Malgorzata Kamocka and Khalid Mohammad and Saunders, {Mary R.} and Hongge Li and Jennifer Speth and Nadia Carlesso and Theresa Guise and Louis Pelus",
year = "2017",
month = "12",
day = "1",
doi = "10.1172/JCI94687",
language = "English (US)",
volume = "127",
pages = "4527--4540",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "12",

}

TY - JOUR

T1 - Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells

AU - Singh, Pratibha

AU - Hoggatt, Jonathan

AU - Kamocka, Malgorzata

AU - Mohammad, Khalid

AU - Saunders, Mary R.

AU - Li, Hongge

AU - Speth, Jennifer

AU - Carlesso, Nadia

AU - Guise, Theresa

AU - Pelus, Louis

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Endothelial cells (ECs) are components of the hematopoietic microenvironment and regulate hematopoietic stem and progenitor cell (HSPC) homeostasis. Cytokine treatments that cause HSPC trafficking to peripheral blood are associated with an increase in dipeptidylpeptidase 4/CD26 (DPP4/CD26), an enzyme that truncates the neurotransmitter neuropeptide Y (NPY). Here, we show that enzymatically altered NPY signaling in ECs caused reduced VE-cadherin and CD31 expression along EC junctions, resulting in increased vascular permeability and HSPC egress. Moreover, selective NPY2 and NPY5 receptor antagonists restored vascular integrity and limited HSPC mobilization, demonstrating that the enzymatically controlled vascular gateway specifically opens by cleavage of NPY by CD26 signaling via NPY2 and NPY5 receptors. Mice lacking CD26 or NPY exhibited impaired HSPC trafficking that was restored by treatment with truncated NPY. Thus, our results point to ECs as gatekeepers of HSPC trafficking and identify a CD26-mediated NPY axis that has potential as a pharmacologic target to regulate hematopoietic trafficking in homeostatic and stress conditions.

AB - Endothelial cells (ECs) are components of the hematopoietic microenvironment and regulate hematopoietic stem and progenitor cell (HSPC) homeostasis. Cytokine treatments that cause HSPC trafficking to peripheral blood are associated with an increase in dipeptidylpeptidase 4/CD26 (DPP4/CD26), an enzyme that truncates the neurotransmitter neuropeptide Y (NPY). Here, we show that enzymatically altered NPY signaling in ECs caused reduced VE-cadherin and CD31 expression along EC junctions, resulting in increased vascular permeability and HSPC egress. Moreover, selective NPY2 and NPY5 receptor antagonists restored vascular integrity and limited HSPC mobilization, demonstrating that the enzymatically controlled vascular gateway specifically opens by cleavage of NPY by CD26 signaling via NPY2 and NPY5 receptors. Mice lacking CD26 or NPY exhibited impaired HSPC trafficking that was restored by treatment with truncated NPY. Thus, our results point to ECs as gatekeepers of HSPC trafficking and identify a CD26-mediated NPY axis that has potential as a pharmacologic target to regulate hematopoietic trafficking in homeostatic and stress conditions.

UR - http://www.scopus.com/inward/record.url?scp=85037070891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037070891&partnerID=8YFLogxK

U2 - 10.1172/JCI94687

DO - 10.1172/JCI94687

M3 - Article

C2 - 29130940

AN - SCOPUS:85037070891

VL - 127

SP - 4527

EP - 4540

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 12

ER -